Publication: Effects of Dopaminergic Compounds on Carbonic Anhydrase Isozymes I, II, and VI
| dc.authorscopusid | 23013520200 | |
| dc.authorscopusid | 23027537500 | |
| dc.authorscopusid | 6701789599 | |
| dc.authorscopusid | 7102904152 | |
| dc.contributor.author | Şentürk, M. | |
| dc.contributor.author | Ekinci, D. | |
| dc.contributor.author | Göksu, S. | |
| dc.contributor.author | Supuran, C.T. | |
| dc.date.accessioned | 2020-06-21T14:27:45Z | |
| dc.date.available | 2020-06-21T14:27:45Z | |
| dc.date.issued | 2012 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Şentürk] Murat, Department of Chemistry, Aǧrı İbrahim Çeçen Üniversitesi, Agri, Agri, Turkey; [Ekinci] Deniz, Department of Agricultural Biotechnology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Göksu] Süleyman, Department of Chemistry, Atatürk Üniversitesi, Erzurum, Erzurum, Turkey; [Supuran] Claudiu T., Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Florence, FI, Italy | en_US |
| dc.description.abstract | Studies on carbonic anhydrase (CA, EC 4.2.1.1) inhibitors have increased due to several therapeutic applications while there are few investigations on activators. Here we investigated CA inhibitory and activatory capacities of a series of dopaminergic compounds on human carbonic anhydrase (hCA) isozymes I, II, and VI. 2-Amino-1,2,3,4-tetrahydronaphthalene-6,7-diol hydrobromide and 2-amino-1,2,3,4-tetrahydronaphthalene-5,6-diol hydrobromide were found to show effective inhibitory action on hCA I and II whereas 2-amino-5,6-dibromoindan hydrobromide and 2-amino-5-bromoindan hydrobromide exhibited only moderate inhibition against both isoforms, being more effective inhibitors of hCA VI. Ki values of the molecules 36 were in the range of 41.12-363 μM against hCA I, of 0.381-470 μM against hCA II and of 0.578-1.152 μM against hCA VI, respectively. Compound 7 behaved as a CA activator with K<inf>A</inf> values of 27.3 μM against hCA I, of 18.4 μM against hCA II and of 8.73 μM against hCA VI, respectively. © 2012 Informa UK, Ltd. | en_US |
| dc.identifier.doi | 10.3109/14756366.2011.591290 | |
| dc.identifier.endpage | 369 | en_US |
| dc.identifier.issn | 1475-6366 | |
| dc.identifier.issn | 1475-6374 | |
| dc.identifier.issue | 3 | en_US |
| dc.identifier.pmid | 21699374 | |
| dc.identifier.scopus | 2-s2.0-84860360752 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 365 | en_US |
| dc.identifier.uri | https://doi.org/10.3109/14756366.2011.591290 | |
| dc.identifier.volume | 27 | en_US |
| dc.identifier.wos | WOS:000303330100006 | |
| dc.identifier.wosquality | Q1 | |
| dc.language.iso | en | en_US |
| dc.publisher | Taylor & Francis Ltd | en_US |
| dc.relation.ispartof | Journal of Enzyme Inhibition and Medicinal Chemistry | en_US |
| dc.relation.journal | Journal of Enzyme Inhibition and Medicinal Chemistry | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Carbonic Anhydrase | en_US |
| dc.subject | Dopaminergic | en_US |
| dc.subject | HCA I | en_US |
| dc.subject | HCA II | en_US |
| dc.subject | Inhibitor | en_US |
| dc.title | Effects of Dopaminergic Compounds on Carbonic Anhydrase Isozymes I, II, and VI | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication |
